Cutler Group LP Novartis Ag Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $355,085 - $434,844	-4,700 Reduced 97.92%	100 $0
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $37,305 - $43,630	500 Added 11.63%	4,800 $23,000
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $152,988 - $178,125	-1,900 Reduced 30.65%	4,300 $9,000
Q1 2022 Apr 14, 2022	BUY	$80.11 - $90.62 $496,682 - $561,844	6,200 New	6,200 $3,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $353,350 - $495,050	-5,000 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$73.66 - $82.02 $368,300 - $410,100	-5,000 Reduced 50.0%	5,000 $71,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $669,400 - $774,300	10,000 New	10,000 $3,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.